These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 35914620)

  • 1. Dissecting causal relationships between nonalcoholic fatty liver disease proxied by chronically elevated alanine transaminase levels and 34 extrahepatic diseases.
    Liu Z; Suo C; Fan H; Zhang T; Jin L; Chen X
    Metabolism; 2022 Oct; 135():155270. PubMed ID: 35914620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal relationship between nonalcoholic fatty liver disease and different sleep traits: a bidirectional Mendelian randomized study.
    Sun Z; Ji J; Zuo L; Hu Y; Wang K; Xu T; Wang Q; Cheng F
    Front Endocrinol (Lausanne); 2023; 14():1159258. PubMed ID: 37334291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and complications in type 1 and type 2 diabetes: A Mendelian randomization study.
    Liu N; Wang G; Liu C; Liu J; Huang S; Zhou Y; Xiao E
    Diabetes Obes Metab; 2023 Feb; 25(2):365-376. PubMed ID: 36181433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 1 diabetes mellitus and non-alcoholic fatty liver disease: a two-sample Mendelian randomization study.
    Tuo L; Yan LT; Liu Y; Yang XX
    Front Endocrinol (Lausanne); 2024; 15():1315046. PubMed ID: 38681765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study.
    Yu Y; Yu Y; Wang Y; Chen Y; Wang N; Wang B; Lu Y
    Front Endocrinol (Lausanne); 2023; 14():1156381. PubMed ID: 37223039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study.
    Cui A; Xiao P; Fan Z; Lei J; Han S; Zhang D; Wei X; Wang P; Zhuang Y
    Front Endocrinol (Lausanne); 2023; 14():1215790. PubMed ID: 37621646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nonalcoholic fatty liver disease and risk of erectile dysfunction: A bidirectional two-sample mendelian randomization study].
    Cheng P; Wang YW; Shen YJ
    Zhonghua Nan Ke Xue; 2023 Aug; 29(8):705-710. PubMed ID: 38619516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the role of non-alcoholic fatty liver disease in cardiovascular diseases and type 2 diabetes: a Mendelian randomization study in Europeans and East Asians.
    Au Yeung SL; Borges MC; Wong THT; Lawlor DA; Schooling CM
    Int J Epidemiol; 2023 Jun; 52(3):921-931. PubMed ID: 36367831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mendelian Randomization Analysis Reveals No Causal Relationship Between Nonalcoholic Fatty Liver Disease and Severe COVID-19.
    Li J; Tian A; Zhu H; Chen L; Wen J; Liu W; Chen P
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1553-1560.e78. PubMed ID: 35124268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between nonalcoholic fatty liver disease and type 2 diabetes: A bidirectional two-sample mendelian randomization study.
    Ni X; Tong C; Halengbieke A; Cao T; Tang J; Tao L; Zheng D; Han Y; Li Q; Yang X
    Diabetes Res Clin Pract; 2023 Dec; 206():110993. PubMed ID: 37931882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease: A 2-Sample Bidirectional Mendelian Randomization Study.
    Li S; Fu Y; Liu Y; Zhang X; Li H; Tian L; Zhuo L; Liu M; Cui J
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3497-e3503. PubMed ID: 35363278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between leptin and NAFLD: a two-sample Mendelian randomization study.
    Guo Z; Du H; Guo Y; Jin Q; Liu R; Yun Z; Zhang J; Li X; Ye Y
    Eur J Med Res; 2023 Jul; 28(1):215. PubMed ID: 37400922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study.
    Peng H; Wang S; Wang M; Ye Y; Xue E; Chen X; Wang X; Fan M; Gao W; Qin X; Wu Y; Chen D; Li J; Hu Y; Wang L; Wu T
    Metabolism; 2022 Aug; 133():155220. PubMed ID: 35618017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal association of nonalcoholic fatty liver disease with 22 extrahepatic cancers: A Mendelian randomization study.
    Xie J; Gao H; Liu C; Pan Y; Xu C; Xu L
    Hepatol Res; 2024 Mar; 54(3):261-271. PubMed ID: 37877524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mendelian randomization explores the causal relationships between obesity, diabetes, inflammation and nonalcoholic fatty liver disease.
    Wang X; Zhao D; Cheng L; Gao J; Li J; Geng C
    Medicine (Baltimore); 2023 Sep; 102(38):e34638. PubMed ID: 37747017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between NAFLD and coronary artery disease: A Mendelian randomization study.
    Ren Z; Simons PIHG; Wesselius A; Stehouwer CDA; Brouwers MCGJ
    Hepatology; 2023 Jan; 77(1):230-238. PubMed ID: 35441719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine, folate, and nonalcoholic fatty liver disease: a systematic review with meta-analysis and Mendelian randomization investigation.
    Yuan S; Chen J; Dan L; Xie Y; Sun Y; Li X; Larsson SC
    Am J Clin Nutr; 2022 Dec; 116(6):1595-1609. PubMed ID: 36205540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Causal relationships between neuropsychiatric disorders and nonalcoholic fatty liver disease: A bidirectional Mendelian randomization study.
    Wang S; Gao H; Lin P; Qian T; Xu L
    BMC Gastroenterol; 2024 Sep; 24(1):299. PubMed ID: 39227758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study.
    Yuan S; Chen J; Li X; Fan R; Arsenault B; Gill D; Giovannucci EL; Zheng JS; Larsson SC
    Eur J Epidemiol; 2022 Jul; 37(7):723-733. PubMed ID: 35488966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal effects of non-alcoholic fatty liver disease on osteoporosis: a Mendelian randomization study.
    Zhou Y; Ni Y; Wang Z; Prud'homme GJ; Wang Q
    Front Endocrinol (Lausanne); 2023; 14():1283739. PubMed ID: 38149094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.